A phase I clinical study of biweekly carboplatin and gemcitabine in patients with advanced solid tumors.

@article{Kumar2006API,
  title={A phase I clinical study of biweekly carboplatin and gemcitabine in patients with advanced solid tumors.},
  author={P. Saidesh Kumar and Mani Keshtgarpour and H M Suresh Kumar and Arkadiusz Z. Dudek},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2006},
  volume={24 18_suppl},
  pages={12024}
}
12024 Background: Carboplatin (CBDCA) and gemcitabine (GEM) in combination is used commonly in lung cancer and is administered on a 21 day cycle. The purpose of this study was to determine the maximum tolerated dose (MTD) of CBDCA and GEM administered on a biweekly schedule and to assess safety and efficacy of this schedule. METHODS GEM was given… CONTINUE READING